From 1991, our research group and others have been investigating children with short stature
who were born small for gestational age (SGA), both before and during treatment with
biosynthetic growth hormone (GH). In 2005, GH treatment was licensed for short SGA children in
the Netherlands. Many questions though remained unanswered, especially about the efficacy of
GH treatment when started at an older age, just before or during puberty.
This doctoral thesis describes studies evaluating short adolescents born SGA who were
treated with GH, and additionally with postponement of puberty by gonadotropin-releasing
hormone analogue (GnRHa).
No comments:
Post a Comment